Wenxiang Wang

发表

Pharmacokinetics, Pharmacodynamics, and Tolerability of Single Ascending Doses of RCT-18 in Chinese Patients with Rheumatoid Arthritis

Xia Chen, Ji Jiang, P. Hu, 2014, Clinical Pharmacokinetics.

Pharmacokinetics, pharmacodynamics, short term efficacy and safety of RCT-18, a novel BLyS/APRIL fusion protein, in patients with rheumatoid arthritis.

Xia Chen, Ji Jiang, P. Hu, 2016, British journal of clinical pharmacology.

Therapeutic effects of TACI-Ig on collagen-induced arthritis by regulating T and B lymphocytes function in DBA/1 mice.

M. Huang, Wei Wei, Yingqi Wu, 2011, European journal of pharmacology.

A Randomized Controlled Phase IIb Trial of Antigen-Antibody Immunogenic Complex Therapeutic Vaccine in Chronic Hepatitis B Patients

Zheng-hong Yuan, Y. Wen, Hui-fen Wang, 2008 .

An open-label, multicenter, phase Ib study to evaluate RC48-ADC in patients with HER2-positive metastatic breast cancer.

Bing-he Xu, Qingyuan Zhang, Jiayu Wang, 2018 .

Randomized Phase 2 Trial of Telitacicept in Patients With IgA Nephropathy With Persistent Proteinuria

Hong Zhang, J. Lv, L. Zuo, 2022, Kidney international reports.

Pharmacokinetics, Pharmacodynamics, Safety, and Clinical Activity of Multiple Doses of RCT‐18 in Chinese Patients With Systemic Lupus Erythematosus

Xia Chen, Ji Jiang, P. Hu, 2016, Journal of clinical pharmacology.

Therapeutic effects of TACI-Ig on collagen-induced arthritis by regulating T and B lymphocytes function in DBA/1 mice.

Wei Wei, Yingqi Wu, Lingling Zhang, 2011, European journal of pharmacology.

An open-label, dose-escalation phase I study to evaluate RC48-ADC, a novel antibody-drug conjugate, in patients with HER2-positive metastatic breast cancer.

Bing-he Xu, Jiayu Wang, Wenxiang Wang, 2018 .